The International Journal of Innovations in Oncology Pharmacy Practice (IJIOPP) is a peer-reviewed, open-access journal committed to publishing high-quality research and scholarly work focused on the evolving role of pharmacy in oncology care. IJIOPP serves as a specialized platform for the dissemination of original research, clinical innovations, and best practices in the field of oncology pharmacy.
Our Mission
Our mission is to support the advancement of pharmaceutical care in oncology by promoting innovation, collaboration, and evidence-based approaches. We aim to empower oncology pharmacists, clinical researchers, and healthcare professionals with cutting-edge knowledge that enhances the quality of care and outcomes for cancer patients.
Our Vision
To be a leading global journal that fosters the integration of scientific research and clinical practice in oncology pharmacy, and serves as a beacon for innovative pharmaceutical strategies in cancer treatment and supportive care.
Key Areas of Focus
- Development and evaluation of oncology-specific pharmaceutical services
- Innovations in cancer drug therapy, formulation, and delivery
- Clinical case reports and studies in oncology pharmacy practice
- Personalized and precision oncology pharmacotherapy
- Patient-centered interventions and supportive care pharmacology
- Pharmacovigilance, safety monitoring, and adverse event management
- Educational frameworks and leadership in oncology pharmacy
- Integration of digital tools, AI, and telepharmacy in cancer care
Who We Serve
IJIOPP is designed for oncology pharmacists, clinical researchers, academic scholars, pharmaceutical scientists, oncology clinicians, and health policy professionals who are engaged in improving cancer care through pharmaceutical innovation.
We invite contributions from professionals across the globe who are committed to shaping the future of oncology pharmacy through scholarly collaboration and knowledge exchange.
